Cronos Group Future Growth
Future criteria checks 4/6
Cronos Group wird ein jährliches Wachstum der Erträge und Einnahmen um 78.1% bzw. 13.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich grow um 79.2% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -3.2% betragen.
Key information
62.4%
Earnings growth rate
64.7%
EPS growth rate
| Pharmaceuticals earnings growth | 36.8% |
| Revenue growth rate | 10.3% |
| Future return on equity | -3.3% |
| Analyst coverage | Good |
| Last updated | 25 Mar 2024 |
Recent future growth updates
Recent updates
Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce
Apr 01
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth
Mar 02Revenues Tell The Story For Cronos Group Inc. (TSE:CRON)
Feb 02Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth
Nov 09We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely
Jul 17Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors
Jun 20We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth
Feb 09A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)
Oct 12We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate
Sep 10Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 12We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth
May 19Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?
Jul 29An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued
Apr 08Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?
Mar 04What You Need To Know About Cronos Group Inc.'s (TSE:CRON) Investor Composition
Jan 22
Does Cronos Group's (TSE:CRON) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 137 | 2 | -15 | -1 | 3 |
| 12/31/2025 | 120 | -8 | -13 | -8 | 5 |
| 12/31/2024 | 101 | -13 | -13 | -2 | 7 |
| 12/31/2023 | 87 | -70 | -46 | -43 | N/A |
| 9/30/2023 | 91 | -115 | -86 | -84 | N/A |
| 6/30/2023 | 86 | -146 | -101 | -97 | N/A |
| 3/31/2023 | 87 | -155 | -108 | -103 | N/A |
| 12/31/2022 | 87 | -155 | -94 | -89 | N/A |
| 9/30/2022 | 91 | -213 | -105 | -101 | N/A |
| 6/30/2022 | 91 | -102 | -124 | -119 | N/A |
| 3/31/2022 | 85 | -263 | -147 | -141 | N/A |
| 12/31/2021 | 65 | -127 | -166 | -154 | N/A |
| 9/30/2021 | 66 | -373 | -179 | -156 | N/A |
| 6/30/2021 | 57 | -381 | -181 | -153 | N/A |
| 3/31/2021 | 51 | -310 | -188 | -153 | N/A |
| 12/31/2020 | 47 | -72 | -180 | -145 | N/A |
| 9/30/2020 | 37 | 101 | -185 | -160 | N/A |
| 6/30/2020 | 31 | 636 | -186 | -152 | N/A |
| 3/31/2020 | 29 | 929 | -192 | -155 | N/A |
| 12/31/2019 | 24 | 1,167 | -170 | -131 | N/A |
| 9/30/2019 | 21 | 1,089 | -131 | -59 | N/A |
| 6/30/2019 | 18 | 479 | -130 | -49 | N/A |
| 3/31/2019 | 13 | 293 | -104 | -11 | N/A |
| 12/31/2018 | 12 | -21 | -96 | -8 | N/A |
| 9/30/2018 | 9 | -8 | -103 | -28 | N/A |
| 6/30/2018 | 7 | -1 | -73 | -16 | N/A |
| 3/31/2018 | 5 | -2 | -51 | -13 | N/A |
| 12/31/2017 | 3 | -1 | -37 | -4 | N/A |
| 9/30/2017 | 4 | 1 | N/A | -4 | N/A |
| 6/30/2017 | 2 | 0 | N/A | -8 | N/A |
| 3/31/2017 | 1 | -1 | N/A | -6 | N/A |
| 12/31/2016 | 0 | -1 | N/A | -5 | N/A |
| 9/30/2016 | 2 | 0 | N/A | -3 | N/A |
| 6/30/2016 | 2 | 0 | N/A | -2 | N/A |
| 3/31/2016 | 3 | 1 | N/A | -1 | N/A |
| 12/31/2015 | 2 | 0 | N/A | -1 | N/A |
| 9/30/2015 | 0 | -4 | N/A | -2 | N/A |
| 6/30/2015 | -1 | -4 | N/A | -2 | N/A |
| 3/31/2015 | -1 | -4 | N/A | -2 | N/A |
| 12/31/2014 | -1 | -4 | N/A | -1 | N/A |
| 9/30/2014 | 0 | -2 | N/A | -1 | N/A |
| 6/30/2014 | 0 | -1 | N/A | -1 | N/A |
| 12/31/2013 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: CRON wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (1.9%).
Ertrag vs. Markt: CRON wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: CRON wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: CRONDie Einnahmen des Unternehmens (12.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (6.9% pro Jahr).
Hohe Wachstumseinnahmen: CRONDie Einnahmen des Unternehmens (13.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: CRON wird voraussichtlich in 3 Jahren unrentabel sein.